Corrections
What we got wrong, and fixed
Every correction to published information, dated, with what it said before and what it says now. Nothing is changed quietly.
- It said
- Said BPC-157 was removed from the FDA’s 503A Category 2 list on 15 April 2026, and said nothing of later events.
- It now says
- Says it was removed in April 2026 (the FDA list is dated 22 April 2026), and adds the 23–24 July 2026 advisory committee vote recommending it for the 503A Bulks List.
- Why
- Re-checked against the FDA’s own pages. The earlier date did not match them, and the July vote had happened since the entry was written.
- It said
- Cited an FDA page that no longer exists (it returned 404).
- It now says
- Cites the FDA’s current Category 2 page and the advisory committee meeting page.
- Why
- A source link that does not open is not a source.
- It said
- Printed monthly search-volume figures ("roughly 301,000 US searches a month") in reader-facing text.
- It now says
- The figures are removed.
- Why
- They were not measured by this project, and a page that asks readers to trust its sources should not print an unsourced number.
- It said
- The “Do not take it if” section on prescription labels was attributed to the label section “OTC — Do Not Use”.
- It now says
- It is attributed to the section it actually comes from, “Contraindications”.
- Why
- Attribution has to name the section the words were taken from.
- It said
- English pages about Bulgarian products printed the register’s form, company and country in Cyrillic.
- It now says
- English pages show the English form, company names transliterated (with companies’ own Latin spellings), and English country names. Bulgarian pages are unchanged.
- Why
- A reader who chose English saw Bulgarian, which read as the language setting not working.
Found something wrong? A reporting address opens with the public launch. Until then, corrections come from our own re-checks against the sources.